SVG
Improving the R&D Environment
Featured
Report
Bridging Gaps in Clinical Trials: Strategies for Increasing Access and Representation
Despite high levels of spending on health care in the United States—almost double that of peer high-income countries—health...
Read
Report
Featured
Report
Bridging Gaps in Clinical Trials: Strategies for Increasing Access and Representation
Despite high levels of spending on health care in the United States—almost double that of peer high-income countries—health...
Read
Report
SVG
Improving the R&D Environment
Programs
Community-Based Research Infrastructure
COVID-19 revealed in stark terms the price to be paid for the lack of a comprehensive community-based research system that can...
Diversity in Clinical Trials
Developing strategies and policies to increase diversity and inclusion in all stages of clinical research and to change the...
Lessons Learned from COVID-19
While the response to the COVID-19 pandemic exposed many of the fault lines in the biomedical innovation ecosystem that have...
Improving the R&D Environment
Highlights
-
Access Point: Trends in Clinical Trials Transformation #2
FasterCures’ Access Point: Trends in Clinical Trials Transformation is a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and efficiency. Each issue highlights...Read ReportFasterCures’ Access Point: Trends in Clinical Trials Transformation is a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and...
-
From Barriers to Breakthroughs: Funding, Resources, and Support to Improve Clinical Trial Access and Innovation
On Tuesday, June 10, 2025, the Convergence Project held a virtual event, “From Barriers to Breakthroughs: Funding, Resources, and Support to Improve Clinical Trial Access and Innovation,” hosted by FasterCures in partnership with The Multi...Read Article -
Access Point: Trends in Clinical Trials Transformation
FasterCures is launching Access Point: Trends in Trial Transformation, a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and efficiency.Read Report -
Bridging Gaps in Clinical Trials: Strategies for Increasing Access and Representation
Despite high levels of spending on health care in the United States—almost double that of peer high-income countries—health outcomes continue to lag across a wide range of disease conditions. The differences in the incidence, prevalence...Read Report
-
Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard
Since early in the COVID-19 pandemic, FasterCures has been committed to capturing lessons learned and opportunities to improve the biomedical research ecosystem. Our first white paper, Lessons Learned From COVID-19: Are There Silver Linings...Read Report
-
Community-Based Infrastructure for Inclusive Research: Engaging the Private Sector
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical infrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations. A community-based...Read Report
-
Building Community-Based Infrastructure for Inclusive Research: Lessons from the Pandemic for Federal Action
COVID-19 has focused the public’s attention on the racial and ethnic disparities in health outcomes, unequal access to health care, and some communities’ lack of trust and participation in medical research. These problems have been decades...Read Report
-
COVID-19 Silver Linings for Biomedical Innovation: Implementation Roadmap
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not...Read Report -
Lessons Learned From COVID-19: Are There Silver Linings for Biomedical Innovation?
FasterCures wants to ensure that the lessons of the COVID-19 crisis are not lost once the current urgency subsides — not only for combating future infectious diseases, but for conducting every other aspect of biomedical innovation...Read Report